Malaysia Healthcare continues to showcase its excellence during the Malaysia Healthcare Excellence week from 3rd – 8th January 2022, on the grounds of the Malaysia Pavilion in Expo 2020 Dubai, with the participation of many leading industry players in the country such as Thomson Hospital Kota Damansara, TMC Fertility and Women’s Specialist Centre, DoctorOnCall as well as Pharmaniaga, Malaysia’s largest pharmaceutical company.
The Malaysia Healthcare Excellence week was embarked with the launching of Malaysia as Asia’s Hub for the treatment of Hepatitis C at Expo 2020 Dubai.
Malaysia’s positioning as a treatment hub for Hepatitis C is in line with the World Health Organisation’s (WHO) mission to reduce new viral Hepatitis infections by 90% and reduce deaths by viral Hepatitis by 65% by 2030. Using a combination treatment of Ravidasvir and Sofosbuvir, Malaysia will be offering treatment for Hepatitis C with a cure rate of 97% and a cost reduction of 95%, making Malaysia the first country in the world to receive conditional approval to use the treatment.
“This initiative is part of our recovery plans for the healthcare travel industry in Malaysia. We aim to become the global focal point for Hepatitis C treatment. In response to the World Hepatitis Day 2021 theme, “Hepatitis Can’t-Wait”, Malaysia is ready and raring to move forward with a treatment solution for those infected with the disease,” said the Chief Executive Officer of Malaysia Healthcare Travel Council (MHTC), Mohd Daud Mohd Arif.
“With our continuous commitment to excellence, safety, and quality, we are ready to provide the treatment to healthcare travelers from around the world, especially the Middle East market, and Expo 2020 Dubai is the perfect platform for us to showcase our strengths as a leading healthcare destination,” he added.
